The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDMTR.L Regulatory News (DMTR)

  • There is currently no data for DMTR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity and TVR

25 May 2022 14:30

RNS Number : 8077M
DeepMatter Group PLC
25 May 2022
 

 

25 May 2022

 

Issue of Shares and Total Voting Rights

 

DeepMatter Group Plc (AIM: DMTR, "Deepmatter", the "Group"), the digital chemistry data and software company, announces as a result of the subscription to Ordinary Shares in the Company by Alan Aubrey, incoming Chair, application has been made for 200,000,000 new Ordinary Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will become effective and trading will commence at 8.00 a.m. on or around 31 May 2022.

 

Following the subscription, Alan Aubrey will be interested in 207,311,393 Ordinary Shares which represents 5.17 per cent. of the issued share capital as enlarged by the subscription. The subscription price was 0.1 pence per Ordinary Share.

 

The new Ordinary Shares will rank pari passu with the existing shares of the Company. Following Admission, the Company's issued share capital will consist of 4,009,897,281 Ordinary Shares. Accordingly, the figure of 4,009,897,281 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

For more information contact

 

DeepMatter Group Plc 0141 548 8156 Fraser Benson, Chief Financial Officer

Canaccord Genuity Limited (Nominated Advisor and Broker) 020 7523 8000Bobbie Hilliam

Meare Consulting 07990 858548Adrian Duffield

About DeepMatter Group plc 

 

DeepMatter's SmartChemistry™ platform enables scientists across a range of industries, including pharma, biotech, agri-science, scientific publishers and contract research organisations (CROs), to easily capture, access and exploit the vast amounts of data created in chemical reactions.

 

DeepMatter integrates its proprietary chemistry data and proprietary software to significantly improve productivity, efficiency, discovery, safety and sustainability of chemical reactions for its customers.

 

DeepMatter's SmartChemistry™ platform capitalises on the combination of its cloud technology, low cost-sensors, connectivity to laboratory hardware and high-performance computing trends such as artificial intelligence (AI).

 

Visit: www.deepmatter.io and follow @deepmattergroup

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOESELFDIEESEFI
Date   Source Headline
28th Aug 20209:05 amRNSSecond Price Monitoring Extn
28th Aug 20209:00 amRNSPrice Monitoring Extension
19th Aug 20208:54 amRNSHolding(s) in Company
11th Aug 20204:13 pmRNSHolding(s) in Company
6th Aug 202012:30 pmRNSHolding(s) in Company
29th Jul 202012:16 pmRNSHolding(s) in Company
29th Jul 20209:45 amRNSHolding(s) in Company
29th Jul 20209:45 amRNSHolding(s) in Company
23rd Jul 20209:59 amRNSHolding(s) in Company
22nd Jul 20209:05 amRNSSecond Price Monitoring Extn
22nd Jul 20209:00 amRNSPrice Monitoring Extension
21st Jul 20205:11 pmRNSHolding(s) in Company
14th Jul 20207:00 amRNSResults of Placing
13th Jul 20207:00 amRNSPlacing and Subscription to raise £2.1 million
2nd Jul 20204:41 pmRNSSecond Price Monitoring Extn
2nd Jul 20204:36 pmRNSPrice Monitoring Extension
25th Jun 20201:39 pmRNSResult of AGM and Directorate Change
4th Jun 20207:00 amRNSDigitalGlassware to Interface with Waters’ UNIFI
1st Jun 20204:41 pmRNSSecond Price Monitoring Extn
1st Jun 20204:36 pmRNSPrice Monitoring Extension
29th May 20207:00 amRNSFinal Results
26th May 20207:00 amRNSNotice of Results and Investor Presentation
11th May 202011:57 amRNSHolding(s) in Company
1st May 20208:21 amRNSHolding(s) in Company
28th Apr 20204:35 pmRNSPrice Monitoring Extension
14th Apr 20207:00 amRNSContract with Cancer Research UK Beatson Institute
20th Feb 20207:00 amRNSCollaboration with the University of Nottingham
20th Feb 20207:00 amRNSCollaboration with the University of Nottingham
12th Feb 20207:00 amRNSDeepMatter collaborates with University of Leeds
24th Jan 20207:00 amRNSChange of Adviser
21st Jan 20206:10 pmRNSDirector/PDMR Shareholding
16th Dec 20197:00 amRNSDeepMatter Appoints Industry Advisors
9th Dec 20194:40 pmRNSSecond Price Monitoring Extn
9th Dec 20194:35 pmRNSPrice Monitoring Extension
9th Dec 201911:05 amRNSSecond Price Monitoring Extn
9th Dec 201911:00 amRNSPrice Monitoring Extension
9th Dec 20197:00 amRNSDeepMatter collaboration with AstraZeneca
19th Sep 20197:00 amRNSInterim Results
12th Aug 20197:00 amRNSLaunch of DigitalGlassware Online Portal
8th Aug 20197:00 amRNSFirst revenues for DigitalGlassware
3rd Jul 20192:55 pmRNSChange of Registered Address
28th Jun 20197:00 amRNSDirectorate Change
21st Jun 201912:34 pmRNSChange of Adviser
3rd Jun 20193:41 pmRNSHolding(s) in Company
22nd May 201911:19 amRNSResult of AGM
12th Apr 20197:01 amRNSBoard Changes & Appointments to Advisory Committee
12th Apr 20197:00 amRNSFinal Results
11th Apr 20195:12 pmRNSHolding(s) in Company
10th Apr 201912:58 pmRNSHolding(s) in Company
4th Apr 20193:57 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.